Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
96 Cards in this Set
- Front
- Back
Mast Cell Stabilizers
a)indications/role (4) b)ADR's c)2ex |
a1)exercise-induced asthma
a2)2nd line as monotherapy a3)4-6wks to therapeutic response a4)very safe and no ADRs b)NONE c)Cromolyn, Nedocromil |
|
Theophylline
a)indications/role (1) b)PK (2) c)ADR's (4 of many) |
a1)LAST LINE as combo w/ inhaled corticosteroid + other meds
b)half life is 6h; serum levels want at 5-15 c)n/v, irritability, arrhythmias, dizziness |
|
Theophylline drug interactions
a)3 that incr levels b)3 that decr levels c)synergistic toxicity w/ ____ = arrhythmias |
a)CCB, allopurinol, carbamamzepine
b)barbiturates, charcoal, ketoconazole c)sympathomimetics |
|
Omalizumab
a)indications/role (3) b)ADR's (3) |
a1)LAST LINE for pts w/ severe persistent and PERENNIAL ALLERGIC ASTHMA (year round triggers)
a2)great in pts w/ high IgE a3)expensive b1)injetion site rxns b2)HA b3)viral infexns |
|
Systemic Corticosteroids
a)indications/role (2) b)Prolonged ADR's (4) |
a1)SECOND line as combo w/ steroids and LAB2
a2)long term when taken daily b1)cushings, osteoporosis, HTN, glucose intolerance |
|
Principles of asthma pharmacotherapy (6)
|
1)all pts get albuterol for prn stuff
2)use of albuter over 2x/wk = need for long term control therapy 3)selection of therapy is dictated by asthma severity 4)initiate therapy w/ high-end recommendations; then step down as control is achieved 5)after change in therapy reeval in 2-6wks 6)when stable, reeval @ 1-6months for adherence, ADR's, etc |
|
Intermittent asthma severity
a)preferred treatment b)alternative treatment |
a)albuterol prn symptoms
b)exercise-induced symptoms give albuterol/mast cell stabilizer b4 exercise |
|
Mild persistent asthma
a)preferred treatment b)alternative treatment |
a)low dose ICS
b)mast cell stabilizer & LK modifier (especially w/ allergies) |
|
Moderate persistent asthma
a)preferred treatment b)alternative treatment |
a)low/med dose ICS & LA inhaled B2agonist
b)low dose ICS & LK modifier OR theophylline OR zileuton |
|
Severe persistent asthma (level 4)
a)preferred treatment b)alternative treatment |
a)med dose ICS and LA B2agonist
b)med dose ICS and LK modifier OR theophylline OR zileuton |
|
Severe persistent asthma (level 5)
a)preferred treatment b)alternative treatment |
a)high dose ICS and LA B2agonist
b)? |
|
Severe persistent asthma (level 6)
a)preferred treatment b)alternative treatment (2) |
a)high dose ICS and LA B2agonist
b1)AND if needed systemic corticosteroids (omalizumab if pt has allergies) b2)can also consider adding LK modifier, theophylline, zileuton |
|
Risk factors for death due to asthma (6)
|
1)history of severe exacerbations (intubation/ICU)
2)2 or greater hospitalizations in past year 3)4 or greater ED visits in past year 4)greater than 2 SABA canisters per month 5)low socioeconomic status/inner city residence 6)illicit drug use |
|
Classification of chronic asthma symptoms does NOT...
|
determine the severity of acute asthma exacerbations
|
|
Classifying severity of acute asthma
a)Mild b)moderate c)severe d)Severe and Life threateneing |
a)FEV over 70%; O2 sat over 95%
b)FEV 40-70%; O2 sat 90-95% c)FEV less than 40%; O2sat less than 90% d)FEV under 25% |
|
3 main treatments of acute asthma
|
1)oxygen
2)bronchodilators (albuterol) 3)corticosteroids |
|
Albuterol adult ACUTE dose (2)
|
Nebulizer 5mg q20min x3, then q1-4h prn
MDI (90mcg/puff) 4-8puffs q20min x3, then q1-4h prn |
|
Albuterol pediatric ACUTE dose (2)
|
Nebulizer (0.15mg/kg, min 2.5mg) 1 dose q20min x3, then 1-4h prn
MDI 4-8puffs q20min x3, then q1-4h prn |
|
When to use albuterol nebulizer
|
ONLY if can't use MDI b/c they have the same efficacy
|
|
Ipatropium role in acute asthma?
|
in SEVERE exacerbations w/ high dose albuterol; never monotherapy b/c delayed onset
|
|
Ipatropium ACUTE adult dose
|
Nebulizer (0.5mg) 1 dose q20min x3, then q1-4h prn
|
|
Ipatropium ACUTE pediatric dose
|
Nebulizer (0.25mg) 1 dose q20min x3, then q1-4h prn
|
|
Theophylline and acute asthma
|
NOT USED IN ACUTE ASTHMA
|
|
Systemic B2agonists
a)agents (2) b)when to use and why? |
a1)epinephrine
a2)terbutaline (brethine) b)emergency situations ONLY, b/c no advantage over inhalation therapy |
|
Inhlaled LABA's and acute asthma (2)
|
1)hold LABA while recieveing frequent albuterol treatments to decr SE's
2)NOT indicated in acute asthma |
|
Systemic corticosteroids and acute asthma (4)
|
1)use methylprednisolone or prednisone
2)used in all pts w/ exacerbation 3)speed resolution of airflow obstruction and reduce relapse rate 4)oral and IV prednisone have equal efficacy |
|
Ratio of methylprednisolone and prednisone
|
methylprednisolone 4mg = prednisone 5mg
|
|
Prednisone/Methylprednisolone adult ACUTE dose
|
40-80mg/day in 1-2doses until FEV1 reaches 70% (complete 5-10d course)
|
|
Prednisone/Methylprednisolone pediatric ACUTE dose
|
1mg/kg/day (max 60mg/day) in 2 doses until FEV1 reaches 70% (complete 5-10d course)
|
|
Systemic corticosteroids in acute astham ADR's (immediate ADR's of em) (5)
|
1)edema
2)HTN 3)insomnia 4)euphoria 5)leukocytosis |
|
Inhaled ICS and acute asthma
|
NOT USED, but con't during exacerbation due to taking long time to act
|
|
LK modifiers and acute asthma (2)
|
1)role in acute asthma has NOT been established
2)safe to con't during the exacerbation |
|
Magnesium Sulfate Infusion and Acute asthma (2)
|
1)helpful in exacerbations that are severe and life threatening
2)helpful in exacerbations that are severe and NOT resonding after 1hr of standard treatments |
|
Helium-Oxygen mixtures and Acute asthma (4)
|
1)mix of 65% He, 35% O2
1)helpful in exacerbations that are severe and life threatening 2)helpful in exacerbations that are severe and NOT resonding after 1hr of standard treatments 3)conflicting results of efficacy |
|
Acute Asthma therapies NOT recommended (4)
|
1)Abx
2)Hydration 3)mucolytics 4)Sedation (codeine) |
|
Mild ACUTE exacerbations treatment (3)
|
1)oxygen not necessary
2)MDI albuterol 4-8puff q20min x3; then q1-4h prn 3)Prednisone 40-80mg po qd for 5-10d |
|
Moderate ACUTE exacerbatinos treatment (4)
|
1)oxygen til O2 sat above 95%
2)Albuterol Neb, 5mg q20min x3, then q1-4h prn OR... 3)MDI albuterol 4-8puff q20min x3; then q1-4h prn 4)Prednisone 40-80mg/day until FEV1 reaches 70% for 5-10d |
|
Severe ACUTE exacerbations treatment (4)
|
1)oxygen til O2 sat above 95%
2)Albuterol Neb, 5mg q20min x3, then q1-4h prn AND IPATROPIUM OR... 3)Albuterol Neb, 15mg 1mg/hr by cont. infusion and ipatropium 4)Prednisone 40-80mg/day until FEV1 reaches 70% for 5-10d NO MDI ALBUTEROL ALL NEBULIZER AT THIS STAGE |
|
Severe & Life Threatening ACUTE exacerbations treatment (3)
|
1)oxygen intubate and ventilate w/ 100% O2
2)Albuterol Neb, 15mg 1mg/hr by cont. infusion and ipatropium 4)IV methylprednisolone b/c of intubation (switch to PO when extubated), 40-80mg/day until FEV1 reaches 70% (complete 5-10d course) NO MDI ALBUTEROL ALL NEBULIZER AT THIS STAGE |
|
MDI
a)advantage (3) b)disadvantage (2) |
a1)convient/portable
a2)inexpensive a3)efficient b1)technique dependent upon hand-breath coordination b2)they do not monitor # of puffs remaining |
|
MDI technique (CLOSED mouth technique) (7)
|
1)shake
2)exhale completely 3)place upright inhaler @ opening of mouth 4)begin slow/deep inhalation 5)actuate canister once after start of inhalation & cont inhalation 6)hold breath for 10s 7)wait 1min and repeat |
|
Difference b/w MDI closed/open mouth technique
|
open mouth the MDI is placed 2in (2fingers) away from open mouth
|
|
Spacers? (3) (w/ MDI)
|
1)provide space b/w MDI mouthpiece and pt
2)minimizes deposition of meds on back of throat 3)allows propellant to evaporate |
|
Chambers (4) (w/ MDI)
|
1)one-way valve
2)eliminates the hand-breath coordination reqd for MDI use 3)eliminates deposition of meds on back of throat 4)masked once for pediatric pts |
|
DPI
a)advantages (4) b)disadvantages (4) |
a1)convenient/portable
a2)less coordination reqd a3)no propellants reqd a4)some tell how many doses are left b1)requires deep/forceful inspiration flow to aerosolize meds b2)may cause more pharyngeal deposition b3)NOT for kids under 5yo b4)if exhale into device, dose is lost |
|
DPI technique (7)
|
1)hold parallel to ground
2)trigger/actuate device once 3)exhale completely (but not into device) 4)place mouthpiece in mouth and close mouth around it 5)breathe in quick/forceful inhalation 6)hold breath for 10s 7)wait 1min b4 repeating for 2nd dose |
|
Nebulizer types (2)
|
1)Jet; aerosolize solution using jet streatm of pressurized gas
2)Ultrasonic; aerosolize solution using high frequency ultrasonic waves by power souce (w/ or w/o a fan) |
|
Nebulizer
a)adv (2) b)disadv (4) |
a1)pt coordination not reqd
a2)can deliver higher doses b1)expensive b2)bulky, not portable b3)requires assembly/preparation b4)more time to admin a dose |
|
Nebulizer technique (5)
|
1)assemble nebulizer
2)add meds and qs w/ sterile solution to nebulizer 3)begin treatment 4)breathe slow, deep inhalations thruout 5)stop treatment when nebuilzer begins to sputter |
|
3 types of pts that need Peak Flow monitoring
|
1)severe persistent
2)moderate persistent 3)any pt w/ history of severe exacerbations |
|
Peak Flow technique (7)
|
1)move indicator to bottom
2)stand up 3)take deep breath 4)place mouthpiece in mouth and close lips around it 5)blow out as hard/fast as you can 6)repeat 2x and record best measurement in log 7)USE EVERY MORNING B4 WAKING B4 ASTHMA MEDICATION TAKEN |
|
Zones of Peak Flow monitoring (3)
|
a)Green (80+% FEV1); cont as usual
b)Yellow (50-80% FEV1); use SABA, call MD to incr daily meds) c)RED (less than 50% FEV1); call MD/ER |
|
Written axn plan instructs pts on what? (5)
|
1)level of control
2)daily management 3)early signs of worsening asthma 4)meds for worsening asthma 5)when to seek medical care |
|
Allergic rhinitis
a)def b)common symptoms (3) |
a)inflammation of nasal mucus membrane in response to exposure to inhaled allergen
b)sneezing, nasal itching, watery rhinorrhea |
|
Seasonal allergic rhinitis (2)
|
1)occur in response to seasonal pollens
2)commonly called "hay fever" |
|
Perennial allergic rhinitis (2)
|
1)occurs greater than 2h per day AND greater than 9months/year
2)happen in response to indoor allergens like (mites, roaches, dander) |
|
Nonallergic rhinitis (5)
|
1)triggered by temp, humidity, pollution, chemicals, spicy foods
2)(-) skin tests, nasal smear for eosinophils 3)can get nasal polyps 4)less itching than allergic rhinitis 5)vasomotor/NARES |
|
Infectious rhinitis (sinusitis) (2)
|
1)cause by viral respiratory infexn or bacterial sinus infexn
2)nasal discharge will be thicker and colored yellow-green |
|
Rhinitis medicamentosa (2)
|
1)caused by long-term use (3-5d) of decongestant nasal sprays or cocaine use
2)rebound congestion due to #1 |
|
Symptoms of allergic rhinits (6)
|
1)paroxysms of sneezing
2)itching (ENT,ears) 3)clear, watery rhinorrhea 4)congestion/snoring 5)postnasal drip (causing cough, hoarseness) 6)pain (face,ear,HA,throat) |
|
First line in allergic rhinitis w/ asthma and 3ex
|
NASAL CORTICOSTEROIDS
1)mometasone 2)fluticasone 3)beclomethasone |
|
Nasal corticosteroids used in younger kids (2)
|
1)fluticasone FUROATE (VERAMYST)
2)mometasone (NASONEX) FOR KIDS UNDER 2 |
|
Systemic Antihistamines (ALLERGIC RHINITIS)
a)role (2) b)2nd gen ADR's (2) |
a1)first line for symptom relief (sneezing, itch, conjunctivitis, rhinorrhea)
a2)more effective @ preventing histamine effects than reversing effects b1)QT prolongation in some b2)especially w/ CYP3A4 drug interactions |
|
2nd Gen AH's that can be used in young kids AND ____ is a metabolite of terfenadine
|
1)zyrtec (6months old)
2)clarinex (6months old) fexofenadine |
|
Nasal Antihistamines (ALLERGIC RHINITIS)
a)role b)ADR's c)ex |
a)2nd line for symptoms of allergic rhinitis
b)drowsy, anticholinergic c)Astelin |
|
Nasal Mast Cell Stabilizers (ALLERGIC RHINITIS)
a)indications b)ADR's (5) |
a)alt to nasal corticosteroids
b)sneeze, burn, irritation, HA, bad taste in mouth |
|
LK modifiers (ALLERGIC RHINITIS)
a)indications (3) |
a)montelukast is only FDA approved agent for AR
b)adv for pts w/ asthma and allergy c)can be used in 6month olds |
|
Systemic decongestants role (2) and ADRs (3) (ALLERGIC RHINITIS)
|
1)first line for symptomatic relief of nasal congestion
2)do not treat allergic rhinitis, just congestion 1)higher risk of stroke w/ HTN 2)avoid in arrhythmias, hyperthyroidism 3)rhinitis medicamentosa |
|
Short acting decongestnat
Intermediate acting Long acting |
SA)phenylephrine
IA)tetrahydrozoline LA)afrin |
|
Nasal Anticholinergics (ALLERGIC RHINITIS)
a)role (3) b)ADR's (3) c)ex |
1)VASOMOTOR RHINITIS
2)not first line 3)additive therapy for rhinorrhea not controlled w/ nasal corticosteroids 1)HA, epistaxis, drynose 1)Atrovent (ipatropium) spray |
|
Systemic Corticosteroids and allergic rhinitis? (2)
|
1)for severe, debillitating allergic rhinitis
2)short course of therapy to provide relief of severe symptoms |
|
Immunotherapy and ALLERGIC RHINITIS (3)
|
1)symptom relief within months but full effects after years
2)used in pts w/ con't symptoms despite appropriate allergen avoidance and drugs 3)give small exposure to allergen to induce tolerance |
|
Preferred treatment of Kids under 3 for allergic rhinitis (2)
|
1)Nasal mast cell stabilizer
AND/OR 1)systemic antihistamine (avoid 1st gen) |
|
Allergic conjunctivitis def's (2)
|
inflammation of conjunctiva in response to allergen
conjunctive is mucous membrance lining eyelids |
|
Pathophysiology of allergic conjunctivitis (3)
|
1)IgE mediated response causes mast cell degranulation of contact w/ allergen
2)release of histamine, PG, LK 3)incr vascular permeability and migration of eosinophils and neutrophils |
|
Symptoms that histamine causes (3)
|
1)itch
2)redness 3)edema |
|
Symptoms that PG's cause (4)
|
1)sensitized nerves
2)enhanced pain b/c of #1 3)edema 4)redness |
|
LK causes what symptoms (3)
|
1)chemotaxis
2)edema 3)vascular permeability |
|
Chemotactic factors from eosinophils and neutrophils cause what symptoms (2)
|
1)cell destruction
2)disruption of ocular surface |
|
Differential diagnosis of allergic conjunctivitis (3)
|
1)itchy=allergy
2)burn=dry eye 3)eye lid stuck together in morning= bacterial infexn |
|
Common allergens causing seasonal/perennial conjunctivitis (5)
|
1)house dust mites
2)grass, tree, weed pollen 3)pets 4)cockroaches 5)mold |
|
Nonpharmachologic treatment of allergic conjunctivitis beside preventing allergies like from asthma triggers (3)
|
1)allergen avoidance
2)cold compress 3)artificial tears |
|
Rx meds used for allergic conjunctivitis (6)
|
1)topical antihistamines
2)oral antihistamines 3)mast cell stabilizers 4)topical NSAIDs 5)corticosteroids 6)immunotherapy |
|
Topical antihistamines and allergic conjunctivitis
a)2meds b)dose c)ADR (2) d)cautions |
a)epinastine (Elestat), azelastine (Optivar)
b)1 drop ou bid c)burn/sting, blurry vision d)wait 10min after putting in to put contacts back in |
|
Oral antihistamines and allergic conjunctivitis
a)which to use (3) b)them vs topical |
a)fexofenadine, claritin, zyrtec
b)oral is less effective |
|
Mast cell stabilizers and allergic conjunctivitis
a)drug b)dose c)ADR (3) |
a)nedocromil (Alocril)
b)1-2drops bid c)bad taste, burning, HA |
|
Combo antihistmaine/Mast cell stabilizer and allergic conjunctivitis
a)drug b)dose c)caution |
a)patanol
b)1-2drops bid c)has benzalkonium which can be absorbed by contact lenses |
|
Combo antihistamine/mast cell stabilizer and allergic conjunctivitis
a)drug b)dose c)caution |
a)Ketotifen (Zaditor)
b)1drop ou bid c)same one as patanol |
|
Topical NSAIDs and allergic conjunctivitis
a)drug b)dose c)ADR |
a)ketorolac (acular)
b)1 drop QID***** c)burning |
|
Corticosteroids and allergic conjunctivitis
a)drug (2) c)dose d)only indicated for... (2) e)other |
a)prednisolone, loteprednol (Lotemax)
b)1-2drops QID***** c1)intraocular pressure needs to be monitored by eye Dr if used more than 10days c2)possible cataract formation, glaucoma, bacterial infexn d)LATER DOWN THE LINE AS FAR AS THERAPIES GO |
|
Immunotherapy and allergic conjunctivitis
a)what is it? b)done where? c)helpful in... |
a)allergen vaccination
b)allergy specialist center c)persistent allergic conjunctivitis and atopic keratoconjunctivitis (SEVERELY ALLERGIC PPL) |
|
OTC Topical decongestants allergic conjunctivitis
a)what ones used? (4) b)good for... c)ADR |
a)phenylephrine, naphazoline, afrin, tetrahydrolazine
b)redness c)rebound vasodilation w/ long term use |
|
OTC Topical Antihistamines and allergic conjunctivitis
a)which used b)combo products (2) |
a)pheniramine
b)Naphacon-A, Visine-A |
|
Treatment steps for seasonal conjunctivitis (3)
|
Step 1)topical antihistamine and/or topical NSAID
Step 2)topical antihistamine w/ vasoconstrictor Step 3)dual axn antihistamine/mast cell stabilizer AND/OR oral AH |
|
Treatment steps for perennial conjunctivitis (2)
|
Step1) topical mast cell stabilizer OR dual axn topical AH/mast cell stabilizer
Step2)immunotherapy or topical corticosteroids |
|
Admin technique of eye drops (4)
|
1)do not touch tip of applicator to eye/fingers
2)tilt head back 3)place drop in conjunctival sack (pull eyelid down) 4)apply gently pressure to corner of eye for 30s-1min (helps stop drainage) |